Trabectedin-related rhabdomyolysis: An uncommon but fatal toxicity
dc.contributor.author | Stoyianni, A. | en |
dc.contributor.author | Kapodistrias, N. | en |
dc.contributor.author | Kampletsas, E. O. | en |
dc.contributor.author | Pentheroudakis, George | en |
dc.contributor.author | Pavlidis, Nicholas | en |
dc.creator | Stoyianni, A. | en |
dc.creator | Kapodistrias, N. | en |
dc.creator | Kampletsas, E. O. | en |
dc.creator | Pentheroudakis, George | en |
dc.creator | Pavlidis, Nicholas | en |
dc.date.accessioned | 2018-06-22T09:53:21Z | |
dc.date.available | 2018-06-22T09:53:21Z | |
dc.date.issued | 2011 | |
dc.identifier.uri | https://gnosis.library.ucy.ac.cy/handle/7/41790 | |
dc.description.abstract | Rhabdomyolysis is defined as the dissolution of striped muscle characterized by the leakage of intracellular muscle components into the circulation, which can ultimately lead to renal failure with a possible fatal outcome. Trabectedin is a potential cause of rhabdomyolysis. Herein, we describe a case of rhabdomyolysis in a female patient with recurrent metastatic leiomyosarcoma of the uterus and who had full recovery, and we review the already published cases in order to identify a common pattern of emergence. | en |
dc.language.iso | eng | en |
dc.source | Tumori | en |
dc.subject | Article | en |
dc.subject | Antineoplastic agents | en |
dc.subject | Doxorubicin | en |
dc.subject | Human | en |
dc.subject | Humans | en |
dc.subject | Aged | en |
dc.subject | Female | en |
dc.subject | Computer assisted tomography | en |
dc.subject | Abdominal pain | en |
dc.subject | Cancer recurrence | en |
dc.subject | Gemcitabine | en |
dc.subject | Human tissue | en |
dc.subject | Dexamethasone | en |
dc.subject | Drug fatality | en |
dc.subject | Docetaxel | en |
dc.subject | Metastasis | en |
dc.subject | Cancer relapse | en |
dc.subject | Outcome assessment | en |
dc.subject | Survival | en |
dc.subject | Cancer radiotherapy | en |
dc.subject | Biological markers | en |
dc.subject | Side effect | en |
dc.subject | Case report | en |
dc.subject | Cancer adjuvant therapy | en |
dc.subject | Leiomyosarcoma | en |
dc.subject | Disease association | en |
dc.subject | Cancer infiltration | en |
dc.subject | Multiple cycle treatment | en |
dc.subject | Drug treatment failure | en |
dc.subject | Postoperative period | en |
dc.subject | Alkylating | en |
dc.subject | Drug interactions | en |
dc.subject | Hydration | en |
dc.subject | Outcome | en |
dc.subject | Trabectedin | en |
dc.subject | Cystectomy | en |
dc.subject | Cancer invasion | en |
dc.subject | Hysterectomy | en |
dc.subject | Kidney failure | en |
dc.subject | Liver function test | en |
dc.subject | Comorbidity | en |
dc.subject | Fatality | en |
dc.subject | Fatal outcome | en |
dc.subject | Uterine neoplasms | en |
dc.subject | Convalescence | en |
dc.subject | Creatine kinase | en |
dc.subject | Creatine kinase blood level | en |
dc.subject | Dioxoles | en |
dc.subject | Diuretic therapy | en |
dc.subject | Nephroureterectomy | en |
dc.subject | Palonosetron | en |
dc.subject | Physiotherapy | en |
dc.subject | Renal insufficiency | en |
dc.subject | Rhabdomyolysis | en |
dc.subject | Sigmoidectomy | en |
dc.subject | Tetrahydroisoquinolines | en |
dc.subject | Uterus biopsy | en |
dc.subject | Uterus sarcoma | en |
dc.title | Trabectedin-related rhabdomyolysis: An uncommon but fatal toxicity | en |
dc.type | info:eu-repo/semantics/article | |
dc.description.volume | 97 | |
dc.description.issue | 2 | |
dc.description.startingpage | 252 | |
dc.description.endingpage | 255 | |
dc.author.faculty | Ιατρική Σχολή / Medical School | |
dc.author.department | Ιατρική Σχολή / Medical School | |
dc.type.uhtype | Article | en |
dc.contributor.orcid | Pavlidis, Nicholas [0000-0002-2195-9961] | |
dc.contributor.orcid | Pentheroudakis, George [0000-0002-6632-2462] | |
dc.gnosis.orcid | 0000-0002-2195-9961 | |
dc.gnosis.orcid | 0000-0002-6632-2462 |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |